Michael Roden Selected Research

Biomarkers (Surrogate Marker)

1/2022	Association of C-Terminal Pro-Endothelin-1 with Mortality in the Population-Based KORA F4 Study.
1/2022	Novel biomarkers of inflammation, kidney function and chronic kidney disease in the general population.
1/2022	Correction to: Neuron-specific biomarkers predict hypo- and hyperalgesia in individuals with diabetic peripheral neuropathy.
1/2022	Evaluation of a Stepped Care Approach to Manage Depression and Diabetes Distress in Patients with Type 1 Diabetes and Type 2 Diabetes: Results of a Randomized Controlled Trial (ECCE HOMO Study).
1/2022	Association of circulating MR-proADM with all-cause and cardiovascular mortality in the general population: Results from the KORA F4 cohort study.
12/2021	Neuron-specific biomarkers predict hypo- and hyperalgesia in individuals with diabetic peripheral neuropathy.
11/2021	Leukocyte Counts and T-Cell Frequencies Differ Between Novel Subgroups of Diabetes and Are Associated With Metabolic Parameters and Biomarkers of Inflammation.
6/2021	Serum uromodulin is inversely associated with biomarkers of subclinical inflammation in the population-based KORA F4 study.
1/2021	A Panel of 6 Biomarkers Significantly Improves the Prediction of Type 2 Diabetes in the MONICA/KORA Study Population.
1/2021	Longitudinal associations between ambient air pollution and insulin sensitivity: results from the KORA cohort study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Roden Research Topics

Disease

158	Insulin Resistance 07/2022 - 03/2002
151	Type 2 Diabetes Mellitus (MODY) 02/2022 - 09/2003
60	Inflammation (Inflammations) 01/2022 - 01/2004
42	Obesity 11/2022 - 01/2002
41	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2022 - 01/2002
30	Non-alcoholic Fatty Liver Disease 05/2022 - 06/2006
21	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 12/2004
19	Diabetes Mellitus 01/2021 - 01/2004
13	Prediabetic State (Prediabetes) 01/2022 - 10/2013
13	Glucose Intolerance 01/2022 - 12/2004
13	Hypertension (High Blood Pressure) 01/2022 - 04/2002
13	Body Weight (Weight, Body) 10/2021 - 01/2007
12	Polyneuropathies (Polyneuropathy) 02/2022 - 01/2015
12	Hyperglycemia 01/2022 - 04/2004
11	Fibrosis (Cirrhosis) 01/2022 - 06/2006
10	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 01/2004
9	Myocardial Infarction 01/2022 - 01/2013
9	Hyperinsulinism (Hyperinsulinemia) 01/2019 - 12/2004
8	Fatty Liver 11/2022 - 03/2015
8	Liver Diseases (Liver Disease) 01/2022 - 08/2002
8	Overweight 01/2022 - 06/2009
8	Stroke (Strokes) 12/2018 - 04/2009
7	Diabetic Neuropathies (Diabetic Neuropathy) 12/2021 - 02/2015
7	Weight Loss (Weight Reduction) 02/2015 - 07/2004
6	Dyslipidemias (Dyslipidemia) 01/2022 - 10/2004
5	Disease Progression 11/2022 - 05/2017
5	Alcoholic Fatty Liver 01/2022 - 01/2019
4	Chronic Renal Insufficiency 01/2022 - 01/2021
4	Coronary Disease (Coronary Heart Disease) 01/2022 - 01/2013
4	Abdominal Obesity 01/2022 - 01/2014
4	Atherosclerosis 01/2021 - 02/2009
4	Heart Failure 01/2021 - 02/2009
4	Gestational Diabetes (Gestational Diabetes Mellitus) 11/2020 - 02/2003
4	Hyperlipidemias (Hyperlipidemia) 01/2020 - 09/2003
4	Neoplasms (Cancer) 12/2014 - 04/2002
4	Mitochondrial Diseases (Mitochondrial Disease) 11/2007 - 10/2004
3	Metabolic Diseases (Metabolic Disease) 10/2021 - 01/2017
3	Necrosis 06/2021 - 07/2013
3	Ischemia 01/2020 - 04/2012

Drug/Important Bio-Agent (IBA)

123	Glucose (Dextrose)FDA LinkGeneric 07/2022 - 01/2002
93	Insulin (Novolin)FDA Link 11/2022 - 01/2002
73	LipidsIBA 01/2022 - 10/2002
55	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2006
26	AdiponectinIBA 01/2022 - 01/2004
21	Nonesterified Fatty Acids (NEFA)IBA 12/2021 - 09/2003
20	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2011
19	AdipokinesIBA 01/2022 - 07/2004
19	Adenosine Triphosphate (ATP)IBA 01/2021 - 01/2006
18	C-Reactive ProteinIBA 01/2022 - 07/2004
18	Triglycerides (Triacylglycerol)IBA 10/2020 - 09/2003
17	CytokinesIBA 10/2020 - 01/2004
13	LeptinIBA 01/2022 - 01/2004
12	Metformin (Glucophage)FDA LinkGeneric 12/2021 - 06/2006
11	Amino Acids FDA Link 12/2021 - 03/2002
10	CholesterolIBA 07/2018 - 12/2004
9	EnzymesIBA 05/2022 - 01/2002
9	DiglyceridesIBA 01/2022 - 07/2013
9	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 09/2005
9	Interleukin-6 (Interleukin 6)IBA 01/2022 - 07/2004
9	Blood Glucose (Blood Sugar)IBA 01/2021 - 01/2004
8	Fatty Acids (Saturated Fatty Acids)IBA 03/2022 - 05/2006
8	HDL CholesterolIBA 01/2022 - 12/2004
8	Pharmaceutical PreparationsIBA 01/2022 - 06/2008
8	C-PeptideIBA 06/2021 - 09/2006
7	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2022 - 05/2010
6	CeramidesIBA 01/2022 - 07/2013
6	FructoseIBA 10/2021 - 10/2013
6	ChemokinesIBA 11/2020 - 01/2011
6	Glucagon (Glukagon)FDA Link 07/2018 - 12/2004
5	Sodium-Glucose Transport ProteinsIBA 01/2022 - 01/2020
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2012
5	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022 - 01/2017
5	InterleukinsIBA 06/2021 - 12/2014
5	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021 - 09/2013
5	IsotopesIBA 01/2020 - 03/2014
5	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 12/2017 - 05/2010
4	empagliflozinIBA 01/2022 - 11/2013
4	Messenger RNA (mRNA)IBA 12/2021 - 07/2013
4	Branched-Chain Amino AcidsIBA 06/2021 - 01/2017
4	Hormones (Hormone)IBA 11/2020 - 06/2006
4	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2019 - 04/2004
4	LDL CholesterolIBA 01/2018 - 01/2008
4	Coffee FDA Link 01/2018 - 02/2015
4	Liver GlycogenIBA 12/2004 - 01/2002
3	Protein Isoforms (Isoforms)IBA 01/2022 - 09/2014
3	25-hydroxyvitamin DIBA 01/2022 - 10/2011
3	UromodulinIBA 01/2022 - 10/2019
3	Peroxidase (Myeloperoxidase)IBA 01/2022 - 01/2018
3	Interleukin-22 (IL-22)IBA 01/2022 - 01/2017
3	MicroRNAs (MicroRNA)IBA 12/2021 - 12/2014
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2021 - 10/2011
3	ThiazolidinedionesIBA 12/2021 - 01/2002
3	Superoxides (Superoxide)IBA 06/2021 - 07/2015
3	Sucrose (Saccharose)IBA 01/2021 - 06/2018
3	SugarsIBA 01/2020 - 07/2013

Therapy/Procedure

19	Therapeutics 01/2022 - 01/2004
13	Glycemic Control 11/2021 - 05/2010
8	Bariatric Surgery 06/2022 - 01/2007
5	Drug Therapy (Chemotherapy) 12/2021 - 12/2012
4	Transplantation 01/2022 - 09/2013